So, we decided to revise the Barriers to Insulin Treatment Questionnaire in Chinese (BIT-C) and select middle-aged and elderly Chinese patients with T2D who were on insulin therapy as the research objects to evaluate the reliability and validity of the BIT-C. The gene discussed is INS; the disease is type 2 diabetes mellitus.